Dr. Kunjan Bhatt, MD
NPI: 1770668758
Total Payments
$332,465
2024 Payments
$28,461
Companies
38
Transactions
1,168
Medicare Patients
9,189
Medicare Billing
$935,897
Payment Breakdown by Category
Consulting$164,611 (49.5%)
Other$104,940 (31.6%)
Food & Beverage$39,577 (11.9%)
Travel$23,189 (7.0%)
Education$148.74 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $164,611 | 91 | 49.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $102,915 | 37 | 31.0% |
| Food and Beverage | $39,577 | 884 | 11.9% |
| Travel and Lodging | $23,189 | 147 | 7.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,025 | 2 | 0.6% |
| Education | $148.74 | 7 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $201,476 | 671 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $61,808 | 138 | $0 (2024) |
| PFIZER INC. | $53,257 | 89 | $0 (2024) |
| CVRx, Inc. | $8,100 | 30 | $0 (2024) |
| ABIOMED | $1,480 | 45 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $1,279 | 18 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $699.02 | 19 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $605.19 | 41 | $0 (2023) |
| Alnylam Pharmaceuticals Inc. | $464.89 | 14 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $371.46 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,461 | 143 | Abbott Laboratories ($18,867) |
| 2023 | $45,835 | 161 | Abbott Laboratories ($21,567) |
| 2022 | $22,960 | 154 | Abbott Laboratories ($11,136) |
| 2021 | $17,092 | 87 | Abbott Laboratories ($10,011) |
| 2020 | $28,584 | 111 | Abbott Laboratories ($15,229) |
| 2019 | $57,608 | 156 | Abbott Laboratories ($42,136) |
| 2018 | $42,475 | 223 | Abbott Laboratories ($27,560) |
| 2017 | $89,451 | 133 | Abbott Laboratories ($54,972) |
All Payment Transactions
1,168 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $153.95 | General |
| Category: Heart Failure | ||||||
| 12/31/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Heart Failure | ||||||
| 12/31/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Heart Failure | ||||||
| 12/31/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: Heart Failure | ||||||
| 12/25/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Consulting Fee | Cash or cash equivalent | $1,042.50 | General |
| Category: Heart Failure | ||||||
| 12/25/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Consulting Fee | Cash or cash equivalent | $1,042.50 | General |
| Category: Heart Failure | ||||||
| 12/20/2024 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.17 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/17/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $115.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Consulting Fee | Cash or cash equivalent | $1,390.00 | General |
| Category: Heart Failure | ||||||
| 12/04/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Consulting Fee | Cash or cash equivalent | $1,042.50 | General |
| Category: Heart Failure | ||||||
| 11/29/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Heart Failure | ||||||
| 11/18/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $39.50 | General |
| Category: Heart Failure | ||||||
| 11/18/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: Heart Failure | ||||||
| 11/15/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $5.28 | General |
| Category: Heart Failure | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $31.14 | General |
| Category: Not Applicable | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/28/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $28.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/28/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $2.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/26/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $3.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,172 | 3,213 | $678,460 | $258,532 |
| 2022 | 29 | 2,029 | 3,154 | $623,903 | $228,484 |
| 2021 | 34 | 2,247 | 2,992 | $608,871 | $213,442 |
| 2020 | 32 | 2,741 | 3,505 | $692,433 | $235,438 |
Total Patients
9,189
Total Services
12,864
Medicare Billing
$935,897
Procedure Codes
131
All Medicare Procedures & Services
131 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 299 | 587 | $163,186 | $80,351 | 49.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 149 | 536 | $108,272 | $50,936 | 47.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 277 | 377 | $77,662 | $35,984 | 46.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 110 | 128 | $50,304 | $17,178 | 34.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 25 | 100 | $53,400 | $15,968 | 29.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 230 | 238 | $48,790 | $12,163 | 24.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 90 | 97 | $25,996 | $9,539 | 36.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 318 | 414 | $24,840 | $4,554 | 18.3% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 38 | 41 | $18,696 | $4,077 | 21.8% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 143 | 157 | $16,799 | $3,924 | 23.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $8,756 | $3,698 | 42.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 34 | 34 | $13,353 | $3,082 | 23.1% |
| 94621 | Test for exercise-induced heart and lung stress | Facility | 2023 | 39 | 41 | $8,528 | $2,144 | 25.1% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Facility | 2023 | 28 | 28 | $11,648 | $1,892 | 16.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,480 | $1,752 | 39.1% |
| 78803 | Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | Facility | 2023 | 41 | 41 | $6,601 | $1,656 | 25.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 26 | 26 | $6,136 | $1,590 | 25.9% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 19 | 19 | $6,346 | $1,536 | 24.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 24 | $3,384 | $1,526 | 45.1% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Office | 2023 | 23 | 38 | $6,004 | $1,470 | 24.5% |
| 93750 | Evaluation of lower heart chamber assist device | Office | 2023 | 11 | 20 | $3,120 | $780.88 | 25.0% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 35 | 43 | $3,569 | $777.86 | 21.8% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 34 | 37 | $2,923 | $640.49 | 21.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 53 | 53 | $2,491 | $592.31 | 23.8% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 29 | 32 | $1,440 | $325.10 | 22.6% |
About Dr. Kunjan Bhatt, MD
Dr. Kunjan Bhatt, MD is a Advanced Heart Failure and Transplant Cardiology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770668758.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kunjan Bhatt, MD has received a total of $332,465 in payments from pharmaceutical and medical device companies, with $28,461 received in 2024. These payments were reported across 1,168 transactions from 38 companies. The most common payment nature is "Consulting Fee" ($164,611).
As a Medicare-enrolled provider, Bhatt has provided services to 9,189 Medicare beneficiaries, totaling 12,864 services with total Medicare billing of $935,897. Data is available for 4 years (2020–2023), covering 131 distinct procedure/service records.
Ad
Practice Information
- Specialty Advanced Heart Failure and Transplant Cardiology
- Other Specialties Cardiovascular Disease
- Location Austin, TX
- Active Since 10/26/2006
- Last Updated 01/26/2022
- Taxonomy Code 207RA0001X
- Entity Type Individual
- NPI Number 1770668758
Products in Payments
- CardioMEMS HF System (Device) $123,915
- ENTRESTO (Drug) $61,691
- VYNDAQEL (Drug) $52,951
- CARDIOMEMS (Device) $37,636
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $12,431
- Barostim Neo System (Device) $8,100
- Circulatory Support (Device) $7,329
- HeartMate 3 Left Ventricular Dev (Device) $7,045
- HeartMate (Device) $4,836
- HeartMate 3 Left Ventricular Assist Device (Device) $3,842
- Impella (Device) $1,480
- 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) $750.19
- HeartMate II LVAS (Device) $639.87
- OPTIMIZER (Device) $575.69
- Optimizer (Device) $555.83
- ONPATTRO (Drug) $464.89
- CentriMag (Device) $452.47
- ASSURITY (Device) $437.96
- LifeVest (Device) $371.46
- UPTRAVI (Drug) $368.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Advanced Heart Failure and Transplant Cardiology Doctors in Austin
Dr. Clay Cauthen, Md, MD
Advanced Heart Failure and Transplant Cardiology — Payments: $118,761
Advanced Heart Failure and Transplant Cardiology $118,761
Dr. Raymond Bietry, M.d, M.D
Advanced Heart Failure and Transplant Cardiology — Payments: $19,242
Advanced Heart Failure and Transplant Cardiology $19,242
Andrew Cheng, Md, MD
Advanced Heart Failure and Transplant Cardiology — Payments: $4,714
Advanced Heart Failure and Transplant Cardiology $4,714